Elanco Animal Health Incorporated (ELAN) earnings
ELAN earnings moved a median of +2.63% by the close. Quarterly and annual ELAN reports and results, each read against the price at its own news timestamp. Back to the ELAN overview →
24 measured ELAN earnings events.
Where these ELAN earnings landedvs 24 measured ELAN earnings reactions
| Middle 50% of ELAN earnings reactions | -0.67% to +9.95% |
|---|---|
| Median reaction (to close) | +2.63% |
| Measured reactions | 24 |
Point-in-time · zero look-ahead
Half of the 24 ELAN earnings events with a measured close landed between -0.67% and +9.95%; 63% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Elanco Confirms Date and Conference Call for Third Quarter 2026 Financial Results Announcement | Press release | +0.45% | -0.13% | |
| Elanco Animal Health Reports Second Quarter 2026 Results | Press release | +0.99% | -3.78% | |
| Form 10-Q Elanco Animal Health For: Jun 30 | SEC filing · Form 10-Q | +0.99% | -3.78% | |
| Elanco Confirms Date and Conference Call for Second Quarter 2026 Financial Results Announcement | Press release | -1.61% | +1.77% | |
| Elanco Animal Health Reports First Quarter 2026 Results | Press release | +1.45% | +13.23% | |
| Form 10-Q Elanco Animal Health For: Mar 31 | SEC filing · Form 10-Q | +1.45% | +13.23% | |
| Elanco Confirms Date and Conference Call for First Quarter 2026 Financial Results Announcement | Press release | +0.09% | -0.39% | |
| Form 10-K Elanco Animal Health For: Dec 31 | SEC filing · Form 10-K | +3.52% | +9.87% | |
| Elanco Animal Health Reports Third Quarter 2025 Results | Press release | -0.22% | -4.55% | |
| Form 10-Q Elanco Animal Health For: Sep 30 | SEC filing · Form 10-Q | -0.22% | -4.55% | |
| Elanco Confirms Date and Conference Call for Third Quarter 2025 Financial Results Announcement | Press release | +0.79% | +3.23% | |
| Elanco Animal Health Reports Second Quarter 2025 Results | Press release | +5.12% | +5.37% | |
| Form 10-Q Elanco Animal Health For: Jun 30 | SEC filing · Form 10-Q | +5.12% | +5.37% | |
| Elanco Confirms Date and Conference Call for Second Quarter 2025 Financial Results Announcement | Press release | -0.20% | +2.04% | |
| Elanco Animal Health Reports First Quarter 2025 Results | Press release | +1.10% | +10.18% | |
| Form 10-Q Elanco Animal Health For: Mar 31 | SEC filing · Form 10-Q | +1.10% | +10.18% | |
| Elanco Confirms Date and Conference Call for First Quarter 2025 Financial Results Announcement | Press release | -1.76% | -4.39% | |
| Form 10-K Elanco Animal Health For: Dec 31 | SEC filing · Form 10-K | -3.44% | -0.47% | |
| Elanco Animal Health Reports Third Quarter 2024 Results | Press release | +3.64% | +9.85% | |
| Form 10-Q Elanco Animal Health For: Sep 30 | SEC filing · Form 10-Q | +3.64% | +9.85% | |
| Elanco Confirms Date and Conference Call for Third Quarter 2024 Financial Results Announcement | Press release | -0.28% | +0.14% | |
| Elanco Animal Health Reports Second Quarter 2024 Results | Press release | +10.24% | +12.27% | |
| Form 10-Q Elanco Animal Health For: Jun 30 | SEC filing · Form 10-Q | +10.24% | +12.27% | |
| Elanco Confirms Date and Conference Call for Second Quarter 2024 Financial Results Announcement | Press release | +0.46% | -1.30% |
Keep exploring
More ELAN: analyst actions → · SEC filings → · ELAN overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| AmerisourceBergen Corporation (ABC) | 1,573 | +0.02% | 51% |
| CTI BioPharma Corp. (CTIC) | 1,481 | -0.33% | 39% |
| Centene Corporation (CNC) | 1,456 | +0.01% | 50% |
| Fluidigm Corporation (FLDM) | 1,452 | 0.00% | 49% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.